Llwytho...
Methotrexate as a Corticosteroid-Sparing Agent for Thyroid Eye Disease
OBJECTIVE: Thyroid eye disease (TED) is generally treated with oral corticosteroid therapy. A steroid sparing drug could be a useful adjunct. We reviewed our experience with methotrexate as a corticosteroid sparing agent to treat TED. METHODS: Retrospective chart review from two eye inflammation cli...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Clin Exp Ophthalmol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4718577/ https://ncbi.nlm.nih.gov/pubmed/26807304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9570.1000422 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|